More than 400,000 meetings are requested in the weeks leading up to the BIO International Convention. Join us for an insightful webinar designed to help service providers optimize their approach to ...

A busy April is flying by. Today, we look at the executive order on drug pricing, the threat of pharmaceutical tariffs, a CDC meeting on immunization practices, and BIO’s appearances at many ...

Today, we have details on the National Security Commission on Emerging Biotechnology’s new report—and why tariffs still threaten biotech, including pharma and ag. (816 words, 4 minutes, 4 seconds) ...

While pharmaceuticals were spared the U.S. tariffs that shook world markets last week, the respite could be short-lived. The impact: 94% of biotech firms anticipate surging manufacturing costs from ...

Another busy week begins with BIO’s new survey of member views on tariffs and a BIO Board member’s congressional testimony on how legislation can help small biotechs. (747 words, 3 minutes, 44 seconds ...

John Crowley, President and CEO of the Biotechnology Innovation Organization (BIO), released the following statement regarding the resignation of Peter Marks from the FDA: “Under the extraordinary ...

At its simplest, biotechnology is technology based on biology - biotechnology harnesses cellular and biomolecular processes to develop technologies and products that help improve our lives and the ...

Explore the webinar opportunities for interactive, online learning about emerging issues in biotechnology public policy, scientific progress, and raising capital, plus methods to benefit from BIO’s ...

Explore how we drive biotechnology innovation. Advancing newer and better medicines, therapeutics, and vaccines is a collective effort that involves an entire ecosystem, not just one person or company ...

"BIO is a crucial trade group representing all biotech and biopharma companies with influence on policies affecting our business and patients with rare diseases in the U.S. Through our participation ...

BIO is in search of dynamic, professional candidates possessing the expertise and education outlined in the job titles listed below. If you are interested in working at BIO, please visit our current ...

This is the only conference focused specifically on intellectual property in biotechnology, featuring the latest insights from biotech IP experts, as well as networking events designed to promote ...